Skip to main content

Table 2 Comparison of the sEMG amplitudes between conditions. P-values of the Wilcoxon tests before and after FDR correction for multiple testing and effect sizes are shown

From: Can Lokomat therapy with children and adolescents be improved? An adaptive clinical pilot trial comparing Guidance force, Path control, and FreeD

 

Comparisons

p-values of the Wilcoxon test

FDR corrected p-values

Effect sizes

M.rectus femoris

GF - PC

0.100

0.150

−0.30

GF - FreeD

0.061

0.150

−0.34

PC - FreeD

0.496

0.496

−0.13

M.vastus medialis

GF - PC

0.173

0.173

−0.25

GF - FreeD

0.020

0.030

−0.43

PC - FreeD

0.002

0.006

−0.56

M.biceps femoris

GF - PC

0.955

0.955

−0.01

GF - FreeD

0.363

0.545

−0.17

PC - FreeD

0.125

0.375

−0.28

M.tibialis anterior

GF - PC

0.133

0.199

−0.30

GF - FreeD

0.023

0.069

−0.45

PC - FreeD

0.701

0.701

−0.08

M.gastrocnemius lateralis

GF - PC

0.209

0.582

−0.26

GF - FreeD

1.000

1.000

0.00

PC - FreeD

0.388

0.582

−0.18

Heart rate

GF - PC

0.069

0.104

−0.33

GF - FreeD

0.047

0.104

−0.36

PC - FreeD

0.427

0.427

−0.15

  1. Abbreviations: FDR False Discovery Rate [50], GF Guidance Force, PC Path Control. Statistically significant data are indicated in bold